At the 6-month mark, the high-dose group saw a 3035% increase in mean glutathione levels within erythrocytes (red blood cells), plasma, and lymphocytes, and a massive 260% increase in buccal cells
Thanks to the FDAs National Priority Voucher program Novo Nordisk should see the FDA's decision within one to two months, resulting in high dose semaglutide availability in 2026
Women experience more slowing effects, especially when taking longer-lasting versions [7]
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties
if anything, tolerability concerns argue for going slower
SREBP, Sterol Regulatory Element-Binding Protein